Asenapine → Asenapine Maleate

HRID 2065864

Reaktionsgleichung

Reaktionsgleichung von HRID 2065864
[Cl:1][C:2]1[CH:3]=[CH:4][C:5]2[O:15][C:14]3[CH:16]=[CH:17][CH:18]=[CH:19][C:13]=3[C@H:8]3[CH2:9][N:10]([CH3:12])[CH2:11][C@@H:7]3[C:6]=2[CH:20]=1.[C:21]([OH:28])(=[O:27])/[CH:22]=[CH:23]\[C:24]([OH:26])=[O:25]>C(O)C>[C:21]([OH:28])(=[O:27])/[CH:22]=[CH:23]\[C:24]([OH:26])=[O:25].[Cl:1][C:2]1[CH:3]=[CH:4][C:5]2[O:15][C:14]3[CH:16]=[CH:17][CH:18]=[CH:19][C:13]=3[C@H:8]3[CH2:9][N:10]([CH3:12])[CH2:11][C@@H:7]3[C:6]=2[CH:20]=1

Komponenten

4

Edukt 2

HCID 163091AsenapineHCID 444266Maleic Acid

Produkt 1

HCID 6917875Asenapine MaleateAusbeute 63 %

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 702EthanolLösungsmittel

Reaktionsbedingungen

Temperatur
60 °C

Versuchsvorschrift

A mixture of 9.52 g of the solid containing trans-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenzo[2,3;6,7]-oxepino[4,5-c]pyrrole obtained in Example 4 and 25 mL of ethanol was heated to 60° C., and then 4.25 g (36.6 mmol) of maleic acid was added to obtain a homogeneous solution. Approximately 0.2 g of active carbon (SEISEI SHIRASAGI, product of Takeda Pharmaceutical Co., Ltd.) was added to the solution and the mixture was stirred at the same temperature for 25 minutes. The mixture was filtered at the same temperature to obtain a filtrate. The filtered active carbon was washed with 10 mL of ethanol and the obtained wash solution was combined with the previously obtained filtrate. The obtained solution was cooled to 40° C., and trans-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenzo[2,3;6,7]-oxepino[4,5-c]pyrrole maleate seed crystals were added. The obtained mixture was cooled to 0-5° C. and then stirred for 2 hours. The precipitated crystals were separated off by filtration, and the crystals were washed with approximately 10 mL of cold ethanol and dried to obtain 7.87 g of trans-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenzo[2,3;6,7]-oxepino[4,5-c]pyrrole maleate as a white solid. The yield was 63% (based on trans-form).

Aufarbeitung

  1. customto obtain a homogeneous solution
  2. additionApproximately 0.2 g of active carbon (SEISEI SHIRASAGI, product of Takeda Pharmaceutical Co., Ltd.) was added to the solution
  3. filtrationThe mixture was filtered at the same temperature
  4. customto obtain a filtrate
  5. washThe filtered active carbon was washed with 10 mL of ethanol
  6. washthe obtained wash solution
  7. temperatureThe obtained solution was cooled to 40° C.
  8. additiontrans-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenzo[2,3;6,7]-oxepino[4,5-c]pyrrole maleate seed crystals were added
  9. temperatureThe obtained mixture was cooled to 0-5° C.
  10. stirringstirred for 2 hours
  11. customThe precipitated crystals were separated off by filtration
  12. washthe crystals were washed with approximately 10 mL of cold ethanol
  13. customdried

Quellen und Nachweise

ORD-Eintrag
ord-8bec4060dc1649f38f6d4884aac84721
Quelldatensatz
uspto-grants-2012_10
Patentnummer
US08288564B2

Verknüpfte Notizen

Wird geladen…